Print This Issue
 
Events | Funding Opportunities | Announcements | News | Resources
 
 
 August 20, 2025
 
 
Events
 
 
 
AUGUST 26, 9–11:00 AM
Celebrate the Unveiling of the First Mobile Prostate Cancer Screening Unit of Its Kind
Chao Family Comprehensive Cancer Center and Ambulatory Care Bldg., 19208 Jamboree Road
 
Learn more
 
AUGUST 29, 10 –11 AM
K12 Scholar Program Informational Meeting
ICTS NIH funded faculty career development. For questions or more information, please contact sgroesbe@hs.uci.edu.
 
Learn more
 
SEPTEMBER 9, 9:25 AM–2:55 PM
NCCN Oncology Policy Summit
The National Press Club, Washington D.C. Discuss policy and practice strategies focused on the rapidly changing AI landscape.
 
Learn more
 
SEPTEMBER 9, 10–11:00 AM
Exploring ecDNA's Impact on Childhood Cancers
Virtual - NCI Webinar Series: Childhood Cancer Data Initiative
 
Learn more
 
SEPTEMBER 19, 7:30 AM–5:30 PM
Breaking Barriers: Trailblazing Innovations in Medical Research
Noble Prize Laureate, Gregg Semenza, PhD
Development of inhibitors to treat cancer
 
Learn more
 
SEPTEMBER 19, 10–11:30 AM
NIH Loan Repayment Programs Information
This informational session is designed to provide an overview of the application process for the November 2025 NIH submission.
 
Learn more
 
 
 
Funding Opportunities
 
 
 
The Mike Slive Foundation
1 year | $50,000 
The 2025–2026 pilot grant cycle for innovative prostate cancer research is now open for applications.
Deadline: September 1
 
Learn more
 
Melanoma Research Alliance Seeks Proposals for 2025–2026 Funding Cycle

Young Investigator Award 
3 years | Up to $85,000/year (up to $225,000 total) 
Biosketch due September 30 | Full proposal due November 6 ​​​​​

Team Science Award 
3 years | Up to $300,000/year (up to $900,000 total) 
LOI due September 25 

Team Science Academic–Industry Partnership Award 
3 years | Up to $300,000/year (up to $900,000 total) 
LOI due September 25  ​​

Pilot Award 
2 years | Up to $50,000/year (up to $100,000 total) 
Full proposal due November 25
 
Learn more
 
NIH Loan Repayment Programs (LRP) – Application Cycle Opens September 1
2 years | Up to $50,000/year in loan repayment 
Offers substantial debt relief and tax support in exchange for a commitment to cancer-focused research. 
Deadline: November 20 
 
Learn more
 
A1 Bridge Funding
UC Irvine Chao Family Comprehensive Cancer Center
1 year | $20,000
Supports cancer research with strong potential to improve treatment, diagnosis, prevention, and patient outcomes. Designed to strengthen and resubmit NIH grant applications.
Rolling Deadline
 
Learn more
 
Research Support Opportunity
UC Irvine Genetic Epidemiology Research Institute
1 year | $2,500
Funds research using NIH All of Us data to advance precision medicine.
Rolling Deadline
 
Learn more
 
 
 
Announcements
 
 
 
Welcome to Christopher Hinton, Clinical Research Coordinator!
Christopher joined the Cancer Center from the Cancer Blood Specialty Clinic in Los Alamitos, where he managed sponsored clinical trials spanning multiple oncology disciplines, including endometrial and cervical carcinoma, lung and breast carcinoma, lymphoma, and leukemia. chinton1@hs.uci.edu
 
Advance Your Research Career – Apply for the Physician Scientist Pathways Certificate Course
For residents, fellows, and junior faculty physicians at UC Irvine pursuing careers in basic, translational, clinical, or epidemiological research. Includes three in-person meetings and three online modules.
Deadline to apply: September 1 
 
Learn more
 
Mentorship, Education & Training (MET) Program - Catalyze your Career in Cancer Research
Partner with senior mentors from the Chao Family Comprehensive Cancer Center (CFCCC) to navigate career and scientific challenges, strengthen your research, and advance your long-term trajectory in cancer research. Early-stage and mid-career faculty are invited to apply for the MET program — a year-long professional development and mentorship opportunity. Deadline to apply: September 22 
 
Learn more
 
NIH Grants & Funding

NIH Shifts Focus to Human-Based Research, Signaling Fewer Animal Studies in Future Funding Opportunities — See How This Change Could Shape Your Next Grant 

New NIH Supplement Model Speeds Approvals for Global Human Subjects Research 

NIH Extends Flexibility for Reporting Basic Experimental Studies With Human Participants — Explore New Compliance Options Beyond September 2025 

New NIH Fellowship Opportunities Now Open — Advance Your Research Career 

NIH Clarifies Impact of Human-Based Research Initiative on Laboratory Animal Proposals 

 
Office of Community Outreach and Engagement (COE)
Strengthen your research impact, enhance clinical trial success, gain trusted community insights, increase study relevance, and accelerate accruals.
 
Learn more
 
 
 
News
 
 
 
First-of-Its-Kind Mobile Unit Brings Prostate Cancer Screening to Orange County
 
Read more
 
Member, Susan O’Brien, MD - Opinion Video, Identifying BTKi Treatment-Related Adverse Events
 
Read more
 
Member, Nicole Sparks, MS, PhD - Turns Out Glass Bottles Have Microplastics Too—Is Anything Actually Safe to Drink From?
 
Read more
 
Member, Nadine Abi-Jaoudeh, MD - New Liquid Embolic Agent for Hypervascular Tumors Gains FDA’s Premarket Approval
 
Read more
 
Member, Andrea De Vizcaya Ruiz, PhD, Shares Expertise About Plastic Containers and Food Safety
 
Read more
 
Member Matt Landry, PhD, RDN - 11 Subtle Signs You’re Not Getting Enough Magnesium, According to Experts
 
Read more
 
Members, Alexandre Chan, PharmD, MPH, and Munjal Acharya, PhD, Honored with COHS Team Research Award
 
Read more
 
 
 

 
Resources
 
Research Programs
Leadership
Advisory Boards
Resources & Funding
Centers & Institutes

Cancer In Focus prior to June 2025
Contact Information
 
UCI Chao Family Comprehensive Cancer Center, 200 S. Manchester Ave, Orange, CA 92868, US

cfccccommunications@hs.uci.edu
Phone 714-456-8000
PAST ISSUES
 
August 6, 2025
July 23, 2025
July 9, 2025
June 25, 2025
All Past Issues
 
 
 
View in Browser | Forward to a Colleague | Subscribe | Unsubscribe
© 2025 UC Irvine. All rights reserved. Click here to contact us.